Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

Name: Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older
License: Public Domain

ModernaTX, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

sars-cov-2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 471508
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.